Skip to main content
SpringerLink
Log in

Concluding Comments/Authors’ Preferences for the Guidelines

  • Chapter
  • First Online:
Medical Treatment of Glaucoma

  • 611 Accesses

Abstract

Glaucoma is a group of diseases that require long-term and even life-long treatment. Each ophthalmologist should master the art of glaucoma medical therapy based on scientific understanding of the etiology of glaucoma and the pharmacological mechanisms of anti-glaucoma medications.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Heijl A, Leske MC, Bengtsson B, Hyman L, Bengtsson B, Hussein M. Reduction of intraocular pressure and glaucoma progression. Arch Ophthalmol. 2002;120:1268–79.

    Article  Google Scholar 

  2. The AGIS Investigators. The advanced glaucoma intervention study (AGIS): the relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol. 2000;130:429–40.

    Article  Google Scholar 

  3. American Academy of Ophthalmology. Preferred practice pattern. 3rd ed. 2015.

    Google Scholar 

  4. European Glaucoma Society. Terminology and guidelines for glaucoma. 4th ed. 2014.

    Google Scholar 

  5. Asia-Pacific Glaucoma Society. Asia Pacific glaucoma guidelines. 3rd ed. 2016.

    Google Scholar 

  6. Chinese Glaucoma Society. Expert consensus on the diagnosis and treatment for primary glaucoma. Chin J Ophthalmol. 2014;50(5):382–3.

    Google Scholar 

  7. Asrani S, Zeimer R, Wilensky J, Gieser D, Vitale S, Lindenmuth K. Large diurnal fluctuations in intraocular pressure are an independent risk factor in patients with glaucoma. J Glaucoma. 2000;9(2):134–42.

    Article  CAS  Google Scholar 

  8. Hedman K, Larsson L-I. The effect of Latanoprost compared with Timolol in African-American, Asian, Caucasian, and Mexican open-angle glaucoma or ocular hypertensive patients. Surv Ophthalmol. 2002;47(Suppl 1):S77–89.

    Article  Google Scholar 

  9. Sun X, Lin M, Duan X, Zhang C, Ming J. Patient satisfaction with fixed-combination bimatoprost/timolol ophthalmic solution: a survey study in patients with glaucoma in China. Patient Prefer Adherence. 2017;28(11):845–52.

    Article  Google Scholar 

  10. Sun X, Dai Y, Chen Y, Yu D-Y, Cringle SJ, Chen J, Kong X, Wang X, Jiang C. Primary angle closure glaucoma: What we know and what we don’t know. Prog Retin Eye Res. 2017;57:26–45.

    Article  Google Scholar 

Download references

Acknowledgment

This book was supported by the top priority of Clinical Medicine Center of Shanghai (2017ZZ01020).

Author information

Authors and Affiliations

  1. Department of Ophthalmology and Visual Science, Eye and ENT Hospital, Shanghai Medical College, Fudan University, Shanghai, China

    Xinghuai Sun & Yi Dai

  2. NHC Key Laboratory of Myopia, Fudan University, Shanghai, China

    Xinghuai Sun

  3. Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, China

    Xinghuai Sun

  4. Shanghai Key Laboratory of Visual Impairment and Restoration, Fudan University, Shanghai, China

    Xinghuai Sun

  5. State Key Laboratory of Medical Neurobiology, Institutes of Brain Science and Collaborative Innovation Center for Brain Science, Fudan University, Shanghai, China

    Xinghuai Sun

  6. NHC Key Laboratory of Myopia (Fudan University), Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, China

    Yi Dai

  7. Shanghai Key Laboratory of Visual Impairment and Restoration (Fudan University), Shanghai, China

    Yi Dai

Authors
  1. Xinghuai Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yi Dai
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Xinghuai Sun or Yi Dai .

Editor information

Editors and Affiliations

  1. Eye & ENT Hospital, Shanghai Medical College of Fudan University, Shanghai, China

    Xinghuai Sun

  2. Eye & ENT Hospital, Shanghai Medical College of Fudan University, Shanghai, China

    Yi Dai

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Sun, X., Dai, Y. (2019). Concluding Comments/Authors’ Preferences for the Guidelines. In: Sun, X., Dai, Y. (eds) Medical Treatment of Glaucoma. Springer, Singapore. https://doi.org/10.1007/978-981-13-2733-9_10

Download citation

  • DOI: https://doi.org/10.1007/978-981-13-2733-9_10

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-13-2732-2

  • Online ISBN: 978-981-13-2733-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation